A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma
Clinical trial NCT01797523 · COMPLETED
Trial details
- NCT number
- NCT01797523
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-07
- Primary completion
- 2026-02-04
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.